ALLMedicine™ Hepatitis D Center
Research & Reviews 537 results
https://doi.org/10.1016/j.ijid.2020.09.004
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases; Hongjaisee S, Khamduang W et. al.
Sep 8th, 2020 - To determine the prevalence of positive hepatitis B surface antigen (HBsAg) and antibody to hepatitis D virus (anti-HDV) and associated factors among migrant sex workers in Chiangmai, Thailand. This cross-sectional study was conducted at various s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410281
PloS One; Cabezas C, Trujillo O et. al.
Aug 7th, 2020 - In 1991, Peru launched the first vaccination program against hepatitis B in children aged under 5 years in the hyperendemic [hepatitis B virus (HBV) and hepatitis D virus (HDV)] province of Abancay. We conducted a cross-sectional study to determin...
https://doi.org/10.1016/j.antiviral.2020.104898
Antiviral Research; Burwitz BJ, Zhou Z et. al.
Aug 7th, 2020 - Hepatitis B virus (HBV) is a member of the Hepadnaviridae family and infects hepatocytes, leading to liver pathology in acutely and chronically infected individuals. Co-infection with Hepatitis D virus (HDV), which requires the surface proteins of...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397625
BMC Infectious Diseases; Wu S, Zhang Y et. al.
Aug 4th, 2020 - Patients coinfected with HBV and hepatitis D virus (HDV) have a greater risk of HCC and cirrhosis. The current study was undertaken to assess HDV genotype distribution and determine clinical characteristics of hepatitis delta virus (HDV) among HBs...
https://doi.org/10.1007/s00705-020-04757-6
Archives of Virology; Fouad HM, Ahmed A et. al.
Aug 3rd, 2020 - In this study, we investigated the seroprevalence of anti-hepatitis D virus (HDV) antibodies in hepatitis B surface antigen (HBsAg)-positive children after 25 years of obligatory vaccination of infants against hepatitis B virus. This cross-section...
Clinicaltrials.gov 543 results
https://doi.org/10.1016/j.ijid.2020.09.004
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases; Hongjaisee S, Khamduang W et. al.
Sep 8th, 2020 - To determine the prevalence of positive hepatitis B surface antigen (HBsAg) and antibody to hepatitis D virus (anti-HDV) and associated factors among migrant sex workers in Chiangmai, Thailand. This cross-sectional study was conducted at various s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410281
PloS One; Cabezas C, Trujillo O et. al.
Aug 7th, 2020 - In 1991, Peru launched the first vaccination program against hepatitis B in children aged under 5 years in the hyperendemic [hepatitis B virus (HBV) and hepatitis D virus (HDV)] province of Abancay. We conducted a cross-sectional study to determin...
https://doi.org/10.1016/j.antiviral.2020.104898
Antiviral Research; Burwitz BJ, Zhou Z et. al.
Aug 7th, 2020 - Hepatitis B virus (HBV) is a member of the Hepadnaviridae family and infects hepatocytes, leading to liver pathology in acutely and chronically infected individuals. Co-infection with Hepatitis D virus (HDV), which requires the surface proteins of...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397625
BMC Infectious Diseases; Wu S, Zhang Y et. al.
Aug 4th, 2020 - Patients coinfected with HBV and hepatitis D virus (HDV) have a greater risk of HCC and cirrhosis. The current study was undertaken to assess HDV genotype distribution and determine clinical characteristics of hepatitis delta virus (HDV) among HBs...
https://doi.org/10.1007/s00705-020-04757-6
Archives of Virology; Fouad HM, Ahmed A et. al.
Aug 3rd, 2020 - In this study, we investigated the seroprevalence of anti-hepatitis D virus (HDV) antibodies in hepatitis B surface antigen (HBsAg)-positive children after 25 years of obligatory vaccination of infants against hepatitis B virus. This cross-section...
News 4 results
https://www.mdedge.com/gihepnews/article/211868/hepatology/hdv-combo-therapy-reduces-viral-loads?channel=346
Will Pass, MDedge News
Nov 8th, 2019 - BOSTON – For most patients with chronic hepatitis D virus (HDV) infection, combination therapy with lonafarnib, ritonavir, and peginterferon may significantly decrease viral loads, based on interim results from the phase IIa LIFT trial. After 6 mo.
https://www.mdedge.com/ccjm/article/110841/hepatology/reply-acute-liver-failure?channel=164
Tavankit Singh, MD, Nancy Gupta, MD et. al.
Aug 1st, 2016 - In Reply: We thank Dr. Homler for bringing hepatitis D as a potential cause of acute liver failure to our attention.
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/51125
Apr 21st, 2015 - The FDA fast-tracked the orphan drug lonafarnib, currently in phase II trials in combination with ritonavir, for treatment of hepatitis D. Physician report cards for colonoscopies? Adenoma detection rates significantly increased with the practice,...
https://www.mdedge.com/jfponline/issue/62805/journal-family-practice-568
Jul 21st, 2000 - Abstract Coinfection with HDV/HBV is associated with severe and sometimes fulminant hepatitis. The possibility of HDV infection should be entertained in the clinical background of fulminant acute HBV or chronic HBV that has suddenly decompensated.
